PLRZ שיעור רווח גולמי Polyrizon Ltd

Polyrizon Ltd fully outsources its laboratory research to external contractors, maintaining no in-house facilities. The business focuses on developing protective nasal sprays designed to block allergens. Gross margin dynamics illustrate the current efficiency of this model, where 0.00 represents the latest metric reading. However, the absence of a commercial product and the early stage of testing leave the company dependent on founder capital.
פילוחים אנליטיים ודוחות נתונים של חברת polyrizon-biotech.com (PLRZ)

Investors are assessing the resilience of Polyrizon Ltd (PLRZ) through the business's ability to generate added value. Gross margin measures the portion of revenue remaining after deducting direct production costs, which determines the efficiency of cost management. This gross profit margin chart allows for a comparison of current expenses against the potential for future B2B licensing of the patent portfolio prior to final FDA approval.